369 related articles for article (PubMed ID: 33110139)
1. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.
Lee J; Kim HS; Cho YK; Kim EH; Lee MJ; Bae IY; Jung CH; Park JY; Kim HK; Lee WJ
Sci Rep; 2020 Oct; 10(1):18323. PubMed ID: 33110139
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
Song DS; Chang UI; Kang SG; Song SW; Yang JM
Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
[TBL] [Abstract][Full Text] [Related]
3. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study.
Park HE; Kwak MS; Kim D; Kim MK; Cha MJ; Choi SY
J Clin Endocrinol Metab; 2016 Aug; 101(8):3134-43. PubMed ID: 27253666
[TBL] [Abstract][Full Text] [Related]
5. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores.
Tsai TY; Hsu PF; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Lu TM; Leu HB
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956339
[TBL] [Abstract][Full Text] [Related]
6. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
7. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity.
Kim SH; Park HY; Lee HS; Jung KS; Lee MH; Jhee JH; Kim TH; Lee JE; Kim HJ; Kim BS; Park HC; Lee BK; Choi HY
Sci Rep; 2020 Jan; 10(1):1025. PubMed ID: 31974458
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
[TBL] [Abstract][Full Text] [Related]
10. Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease.
Kashiwagi K; Yamaguchi A; Shiba S; Taniki N; Inoue N; Takaishi H; Iwao Y; Kanai T
Alcohol; 2020 Dec; 89():1-7. PubMed ID: 32738385
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
Kang YM; Jung CH; Cho YK; Lee SE; Lee MJ; Hwang JY; Kim EH; Park JY; Lee WJ; Kim HK
PLoS One; 2017; 12(4):e0175762. PubMed ID: 28419118
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.
Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
Hepatol Int; 2021 Apr; 15(2):413-423. PubMed ID: 33740211
[TBL] [Abstract][Full Text] [Related]
13. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
15. Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
Behari J; Bradley A; Townsend K; Becich MJ; Cappella N; Chuang CH; Fernandez SA; Ford DE; Kirchner HL; Morgan R; Paranjape A; Silverstein JC; Williams DA; Donahoo WT; Asrani SK; Ntanios F; Ateya M; Hegeman-Dingle R; McLeod E; McTigue K
Dig Dis Sci; 2024 Feb; 69(2):370-383. PubMed ID: 38060170
[TBL] [Abstract][Full Text] [Related]
16. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
17. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease.
Prasoppokakorn T; Chan WK; Wong VW; Pitisuttithum P; Mahadeva S; Nik Mustapha NR; Wong GL; Leung HH; Sripongpun P; Treeprasertsuk S
World J Gastroenterol; 2022 Apr; 28(15):1563-1573. PubMed ID: 35582126
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
19. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
[TBL] [Abstract][Full Text] [Related]
20. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
